NeuroPace, Inc.
NPCE
$15.96
$0.332.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.69M | -2.73M | -3.50M | -8.65M | -6.59M |
| Total Depreciation and Amortization | 513.00K | 522.00K | 487.00K | 477.00K | 462.00K |
| Total Amortization of Deferred Charges | 68.00K | 63.00K | 70.00K | 55.00K | 49.00K |
| Total Other Non-Cash Items | 2.60M | 2.71M | 2.67M | 3.94M | 2.97M |
| Change in Net Operating Assets | -2.39M | -63.00K | -1.67M | 2.09M | -4.37M |
| Cash from Operations | -5.90M | 506.00K | -1.94M | -2.09M | -7.48M |
| Capital Expenditure | -117.00K | -97.00K | -30.00K | -168.00K | -37.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -117.00K | -97.00K | -30.00K | -168.00K | -37.00K |
| Total Debt Issued | -- | 0.00 | -133.00K | 58.57M | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -60.51M | -- |
| Issuance of Common Stock | 10.00K | 723.00K | -- | 205.00K | 70.88M |
| Repurchase of Common Stock | -176.00K | -88.00K | -102.00K | -174.00K | -49.77M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -166.00K | 635.00K | -235.00K | -1.91M | 21.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.18M | 1.04M | -2.21M | -4.16M | 13.59M |